CRO-CSO, Contract Organizations

Previous Page 1 of 11 Next >

Search returned 105 items.

sort by: Title | Author | Publication | Date

FDA Revises Process for Responding to Drug Applications

The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.

Date: 07/09/2008 , Publication: FDA News , Author: FDA

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html

Holding Pattern

The industry experienced solid growth in 2006, but the real action was among the midsize companies.

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423201

Ukraine Emerges as a Viable Location for Global Studies

Trials are on the rise in the country, where recruitment rates are high but custom procedures can pose a problem.

Date: 05/01/2007 , Publication: Applied Clinical Trials , Author: Olena Rudnyeva

http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

Investigative Sites Unlock the Door to Success in India

The clinical development sector in India engaged in global clinical trials for product registration with international regulatory bodies is fast approaching an inflection point.

Date: 05/01/2007 , Publication: Applied Clinical Trials , Author: Nermeen Varawalla

http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

Kid Tested, Government Approved?

Critics claim pharma is too richly rewarded for studying drugs in children. Now, several proposals are on the table that just might change that.

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Kevin A. Schulman

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423216

CRO Shifts in the Outsourcing Market

The CRO market is going through major and unanticipated structural changes

Date: 05/01/2007 , Publication: Applied Clinical Trials , Author: Kenneth A. Getz

http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=4

Opinion: Are Price Controls the New Black?

...the legislation might just passand spell failure for the future of innovative drug development.

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Peter Pitts

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423214

Critical Mass for Critical Path?

...the rewards of collaboration now look greater than the risks....

Date: 05/01/2007 , Publication: Pharmaceutical Executive , Author: Dan Weiner, Mark Hovde

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423202

Opinion: Trigger Points

As pharma begins to confront the looming issue of sales-force downsizing, execs should keep an eye on six factors that can help answer that very question.

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Kim D. Slocum

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=408482

The Best-Sellers List

The 2007 Sales and Marketing Quality Ranking scores the most effective sales forces in the industry.

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Mike Luby, Patrick Howie

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=410701

Previous Page 1 of 11 Next >

Search returned 105 items.